Zonisamide has effects on voltage-gated sodium and calcium channels and inhibits carbonic anhydrase. It has a long half-life (>60 hours) and is thus suitable for once daily administration. Anorexia and reduced serum bicarbonate are common; nephrolithiasis is a less common adverse effect.